Start the conversation
For investors looking to identify the "next big biotech," the dozens of tiny, development-stage players with promising drug candidates are usually the logical place to begin.
But anyone embarking on that exercise today should start their search with Google Inc. (Nasdaq: GOOG).
This isn't a surprise to you, I know. Back in September, we told you about the search giant's first real foray into biotechnology - a company called Calico Life Sciences LLC that had been launched to focus on antiaging research.
This is premium content for Private Briefing subscribers only.